Squarepoint’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4K | Sell |
18,066
-308,459
| -94% | -$349K | ﹤0.01% | 2668 |
|
|
2025
Q1 | $477K | Buy |
326,525
+306,180
| +1,505% | +$447K | ﹤0.01% | 1945 |
|
|
2024
Q4 | $43.3K | Sell |
20,345
-168,152
| -89% | -$358K | ﹤0.01% | 2660 |
|
|
2024
Q3 | $528K | Buy |
188,497
+61,869
| +49% | +$173K | ﹤0.01% | 1722 |
|
|
2024
Q2 | $295K | Buy |
+126,628
| New | +$295K | ﹤0.01% | 1974 |
|
|
2023
Q4 | – | Sell |
-121,792
| Closed | -$386K | – | 2478 |
|
|
2023
Q3 | $386K | Buy |
121,792
+71,855
| +144% | +$228K | ﹤0.01% | 1776 |
|
|
2023
Q2 | $248K | Sell |
49,937
-6,838
| -12% | -$34K | ﹤0.01% | 1966 |
|
|
2023
Q1 | $280K | Sell |
56,775
-143,589
| -72% | -$709K | ﹤0.01% | 1714 |
|
|
2022
Q4 | $1.26M | Sell |
200,364
-45,958
| -19% | -$289K | 0.01% | 982 |
|
|
2022
Q3 | $2.66M | Buy |
+246,322
| New | +$2.66M | 0.01% | 675 |
|
|
2022
Q2 | – | Sell |
-269,320
| Closed | -$2.45M | – | 2095 |
|
|
2022
Q1 | $2.45M | Buy |
+269,320
| New | +$2.45M | 0.01% | 715 |
|
|
2021
Q1 | – | Sell |
-15,792
| Closed | -$399K | – | 2513 |
|
|
2020
Q4 | $399K | Buy |
15,792
+9,892
| +168% | +$250K | ﹤0.01% | 1657 |
|
|
2020
Q3 | $222K | Buy |
+5,900
| New | +$222K | ﹤0.01% | 1868 |
|
|
2020
Q1 | – | Sell |
-54,596
| Closed | -$1.42M | – | 1814 |
|
|
2019
Q4 | $1.42M | Buy |
54,596
+46,049
| +539% | +$1.2M | 0.01% | 1084 |
|
|
2019
Q3 | $233K | Sell |
8,547
-1,854
| -18% | -$50.5K | ﹤0.01% | 1917 |
|
|
2019
Q2 | $279K | Sell |
10,401
-2,599
| -20% | -$69.7K | ﹤0.01% | 1900 |
|
|
2019
Q1 | $376K | Buy |
+13,000
| New | +$376K | ﹤0.01% | 1604 |
|